Literature DB >> 6285433

Immunosuppression in bovine trypanosomiasis: response of cattle infected with Trypanosoma congolense to foot-and-mouth disease vaccination and subsequent live virus challenge.

R T Sharpe, A M Langley, G N Mowat, J A Macaskill, P H Holmes.   

Abstract

The primary and secondary antibody responses to foot-and-mouth disease virus vaccine were examined in cattle infected with Trypanosoma congolense and the response of some of these animals to live foot-and-mouth disease virus challenge was assessed. Infected groups of cattle had rather lower antibody responses than uninfected control cattle after primary vaccination but the antibody titres were not significantly depressed until after secondary vaccination. These levels remained depressed for the duration of the experiment, ie, 183 days. Trypanocidal therapy with diminazene aceturate of infected cattle at the time of vaccination did not significantly improve the antibody response to primary vaccination. Their subsequent response to live virus challenge was somewhat equivocal in that the number of animals protected was not significantly different in comparison to the untreated infected and uninfected controls. It was concluded that trypanosome-infected cattle do not produce optimal responses to foot-and-mouth disease vaccination. Nevertheless, the antibody titres are generally above those considered adequate to confer 95 per cent protection against needle challenge.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6285433

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  8 in total

1.  Gambiense human african trypanosomiasis and immunological memory: effect on phenotypic lymphocyte profiles and humoral immunity.

Authors:  Veerle Lejon; Dieudonné Mumba Ngoyi; Luc Kestens; Luc Boel; Barbara Barbé; Victor Kande Betu; Johan van Griensven; Emmanuel Bottieau; Jean-Jacques Muyembe Tamfum; Jan Jacobs; Philippe Büscher
Journal:  PLoS Pathog       Date:  2014-03-06       Impact factor: 6.823

2.  Recovery of an antiviral antibody response following attrition caused by unrelated infection.

Authors:  Dorothy H L Ng; John J Skehel; George Kassiotis; Jean Langhorne
Journal:  PLoS Pathog       Date:  2014-01-02       Impact factor: 6.823

Review 3.  Escaping Deleterious Immune Response in Their Hosts: Lessons from Trypanosomatids.

Authors:  Anne Geiger; Géraldine Bossard; Denis Sereno; Joana Pissarra; Jean-Loup Lemesre; Philippe Vincendeau; Philippe Holzmuller
Journal:  Front Immunol       Date:  2016-05-31       Impact factor: 7.561

Review 4.  African Trypanosomes Undermine Humoral Responses and Vaccine Development: Link with Inflammatory Responses?

Authors:  Benoit Stijlemans; Magdalena Radwanska; Carl De Trez; Stefan Magez
Journal:  Front Immunol       Date:  2017-05-24       Impact factor: 7.561

5.  Trypanosomiasis-induced B cell apoptosis results in loss of protective anti-parasite antibody responses and abolishment of vaccine-induced memory responses.

Authors:  Magdalena Radwanska; Patrick Guirnalda; Carl De Trez; Bernard Ryffel; Samuel Black; Stefan Magez
Journal:  PLoS Pathog       Date:  2008-05-30       Impact factor: 6.823

6.  Molecular characterization of tsetse's proboscis and its response to Trypanosoma congolense infection.

Authors:  Erick O Awuoche; Brian L Weiss; Aurélien Vigneron; Paul O Mireji; Emre Aksoy; Benson Nyambega; Geoffrey M Attardo; Yineng Wu; Michelle O'Neill; Grace Murilla; Serap Aksoy
Journal:  PLoS Negl Trop Dis       Date:  2017-11-20

Review 7.  Salivarian Trypanosomosis: A Review of Parasites Involved, Their Global Distribution and Their Interaction With the Innate and Adaptive Mammalian Host Immune System.

Authors:  Magdalena Radwanska; Nick Vereecke; Violette Deleeuw; Joar Pinto; Stefan Magez
Journal:  Front Immunol       Date:  2018-10-02       Impact factor: 7.561

Review 8.  Infections With Extracellular Trypanosomes Require Control by Efficient Innate Immune Mechanisms and Can Result in the Destruction of the Mammalian Humoral Immune System.

Authors:  Stefan Magez; Joar Esteban Pinto Torres; Emmanuel Obishakin; Magdalena Radwanska
Journal:  Front Immunol       Date:  2020-03-11       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.